Company intelligence / Profile preview
Wuxi Jiyu Shanhe Pharmaceutical
Wuxi, Jiangsu, Chinajemincare.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Wuxi Jiyu Shanhe Pharmaceutical has approved products in neurology, psychiatry, and respiratory/pharyngeal diseases, plus ongoing clinical development in higher-tech oncology (liposome injection for solid tumors). Herbal compounds and generics dominate commercial output, with newer modalities (e.g. liposomes) under clinical trial. Clinical trial results and pipeline data point to small molecule and herbal drug approvals as well as innovative cancer therapy in early clinical stages
- Therapeutic areas
- OphthalmologyPsychiatryInfectious DiseasesOncologyNeurology
- Modalities
- Herbal medicineSmall moleculeLiposome
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
MedicilonJemincare Group
Beyond the preview
Go deeper on Wuxi Jiyu Shanhe Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wuxi Jiyu Shanhe Pharmaceutical.